We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Stockal+Disclaimer.pdf
25 own
17 watching
Current Price
$1.42
$0.26
(22.41%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
64.45M
52-Week High
1.92000
52-Week Low
0.36000
Average Volume
4.13M
Dividend Yield
--
P/E Ratio
364.1036
Market Capitalization64.45M52-Week High1.9200052-Week Low0.36000Average Volume4.13MDividend Yield--P/E Ratio364.1036What does the Stockal+Disclaimer.pdf do?
The Female Health Company, a medical therapeutics company, develops, manufactures, and markets consumer health care products. The company's pharmaceuticals product portfolio includes Tamsulosin delayed release sachet that is under bioequivalence study for the treatment of benign prostatic hyperplasia; MSS-722, a fixed ratio of trans- and cis-clomiphene citrate isomers, which is under the Phase II clinical trial to treat male infertility caused by testicular dysfunction; APP-944, a zuclomiphene citrate that is under the Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and APP-111, an oral tubulin targeting chemotherapy, which is under the preclinical study to treat metastatic prostate, breast, and ovarian cancers, as well as APP-111/112 oral agents that target colchicine binding site of tubulin for the treatment of gout and familial mediterranean fever. It also provides consumer health and medical devices, including PREBOOST benzocaine wipes for premature ejaculation; and FC2, which is female disposable contraceptive device, as well as FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus. The company primarily serves global agencies, non-government organizations, ministries of health, and other governmental agencies directly, as well as through distribution agreements and other arrangements with commercial partners. It has operations in the United States, Brazil, Zimbabwe, South Africa, Angola, the Democratic Republic of the Congo, Tanzania, Malaysia, Spain, France, the United Kingdom, and internationally. The company was founded in 1896 and is headquartered in Miami, Florida.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
11 months ago
Veru Inc. (NASDAQ:VERU Get Rating) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 15,820,000 shares, a growth of 17.4% from the March 31st total of 13,480,000 shares. Approximately 26.5% of the shares ...
Zolmax
11 months ago
Veru Inc. (NASDAQ:VERU Get Rating) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 15,820,000 shares, a growth of 17.4% from the March 31st total of 13,480,000 shares. Approximately 26.5% of the shares of the ...
Globe Newswire
1 year ago
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it is investigating whether the directors and/or officers of Veru, Inc. (Veru or the Company) (NASDAQ: VERU) breached their fiduciary duties of loyalty, good faith and candor and whether the Company suffered ...
Globe Newswire
1 year ago
MIAMI, FL., March 07, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced that Mitchell Steiner, M.D., Chairman, President and Chief Executive Officer...
Globe Newswire
1 year ago
SAN DIEGO, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Generac Holdings Inc. (NYSE: GNRC) Johnson Fistel, LLP is investigating potential claims on behalf Generac Holdings Inc. (NYSE: GNRC) against certain of its officers and directors. If you are a current, long-term shareholder of Generac holding shares ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
Can Indians buy Stockal+Disclaimer.pdf shares?
How can I buy Stockal+Disclaimer.pdf shares from India?
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
What is today’s traded volume of Stockal+Disclaimer.pdf?
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
Current Price
$1.42
$0.26
(22.41%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.